Cargando…
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
The current frontline symptomatic treatment for Alzheimer’s disease (AD) is whole-body upregulation of cholinergic transmission via inhibition of acetylcholinesterase. This approach leads to profound dose-related adverse effects. An alternative strategy is to selectively target muscarinic acetylchol...
Autores principales: | Bradley, Sophie J., Bourgognon, Julie-Myrtille, Sanger, Helen E., Verity, Nicholas, Mogg, Adrian J., White, David J., Butcher, Adrian J., Moreno, Julie A., Molloy, Colin, Macedo-Hatch, Timothy, Edwards, Jennifer M., Wess, Jurgen, Pawlak, Robert, Read, David J., Sexton, Patrick M., Broad, Lisa M., Steinert, Joern R., Mallucci, Giovanna R., Christopoulos, Arthur, Felder, Christian C., Tobin, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272187/ https://www.ncbi.nlm.nih.gov/pubmed/27991860 http://dx.doi.org/10.1172/JCI87526 |
Ejemplares similares
-
An Antibody Biosensor Establishes the Activation of the M(1) Muscarinic Acetylcholine Receptor during Learning and Memory
por: Butcher, Adrian J., et al.
Publicado: (2016) -
Bitopic Binding Mode of an M(1) Muscarinic Acetylcholine
Receptor Agonist Associated with Adverse Clinical Trial Outcomes
por: Bradley, Sophie J., et al.
Publicado: (2018) -
The metabolome identity: basis for discovery of biomarkers in neurodegeneration
por: Bourgognon, Julie-Myrtille, et al.
Publicado: (2019) -
Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Gregory, Karen J, et al.
Publicado: (2007) -
Activation and allosteric modulation of a muscarinic acetylcholine receptor
por: Kruse, Andrew C., et al.
Publicado: (2013)